All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

 
13x13x1 READ MORE
How To Invest in the Emerging Marijuana Market.
 
LEARN MORE
600x300
InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) Biosynthesis Technology Demonstrates Robust Diversity

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids

13x13x1 READ MORE
600x300
Marapharm Ventures Inc. Announces that it has Purchased an Additional 1.5 Million Units of Veritas Pharma Inc.

Marapharm announced today that it has purchased 1,500,000 units of Veritas Pharma Inc. at a purchase price of $0.28 per unit

13x13x1 READ MORE
600x300
Cronos Group Inc. Announces $15 Million Bought Deal

Cronos Group Inc. (TSX VENTURE: MJN) is pleased to announce that it has entered into a letter of engagement with PI Financial Corp. ("PI") as sole lead underwriter.

13x13x1 READ MORE
600x300
What Can Canada Learn from the US When it Comes to Cannabis Legalization?

From underage access to taxes and enforcement costs, Canada’s swimming in concerns around the impending legalization of cannabis. Drawing on data from the US’s legal-cannabis states, Leafly addresses each of Canada’s fears by addressing how each has played out south of the border.

The post What Can Canada Learn from the US When it Comes to Cannabis Legalization? appeared first on Leafly.

13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 

 
32x32x1   32x32x2  
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.